The increase in SK1 expression in type II pneumocytes in COVID-19+ are consistent with the hyper-proliferative reparative response in the epithelium post-injury reported with SARS-CoV-2 infection and often associated with COVID-pneumonia (13, 24, 28). Here, SPHK1 is linked to COVID-19.